Oncternal Therapeutics Announces Appointment of Salim Yazji as Chief Medical Officer

SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of industry veteran Salim Yazji, M.D., as Chief Medical Officer.

Click here to view original post